Dosing regimens before and following long-term treatment with recombinant factor VIII Fc fusion protein (rFVIIIFc) in adults and adolescents with severe hemophilia A

被引：0

作者：

Konkle, Barbara A. ^{[1
]}

Pasi, K. John ^{[2
]}

Perry, David J. ^{[3
]}

Mahlangu, Johnny ^{[4
]}

Rangarajan, Savita ^{[5
]}

Hanabusa, Hideji ^{[6
]}

Pabinger, Ingrid ^{[7
]}

Lethagen, Stefan ^{[8
,9
]}

Cristiano, Lynda M. ^{[10
]}

Yuan, Huixing ^{[10
]}

Pierce, Glenn F. ^{[10
]}

Allen, Geoffrey ^{[10
]}

机构：

[1] Bloodworks Northwest, Seattle, WA USA

[2] Barts & London Comprehens Care Ctr, London, England

[3] Addenbrookes Hosp, Cambridge, England

[4] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa

[5] Hampshire Hosp NHS Trust, Basingstoke, Hants, England

[6] Ogikubo Hosp, Tokyo, Japan

[7] Med Univ Wien, Vienna, Austria

[8] Sobi, Stockholm, Sweden

[9] Univ Copenhagen, Copenhagen, Denmark

[10] Biogen, Cambridge, MA USA

来源：

HAEMOPHILIA | 2016年 / 22卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：44 / 44

页数：1

共 50 条

[1] Dosing regimens before and following long-term treatment with recombinant factor VIII Fc fusion protein (rFVIIIFc) in children with severe hemophilia A
Nolan, Beatrice
Liesner, Raina
Young, Guy
Mahlangu, Johnny
Pasi, K. John
Lethagen, Stefan
Cristiano, Lynda M.
Yuan, Huixing
Pierce, Glenn F.
Allen, Geoffrey
HAEMOPHILIA, 2016, 22 : 48 - 49
[2] Dosing Regimens Before and During Long-Term Treatment With Recombinant Factor VIII Fc Fusion Protein (rFVIIIFC) in Adults And Adolescents With Severe Haemophilia A: an Updated Analysis Of The Aspire Study
Pasi, K. J.
Perry, D.
Mahlangu, J. N.
Konkle, B.
Rangarajan, S.
Hanabusa, H.
Pabinger, I.
Brown, S. A.
Yuan, H.
Winding, B.
Ramirez-Santiago, A.
Lethagen, S.
Glazebrook, D. V.
HAEMOPHILIA, 2017, 23 : 89 - 90
[3] Dosing Regimens Before and During Long-Term Treatment with Recombinant Factor VIII FC Fusion Protein (rFVIIIFc) in Children with Severe Haemophilia A: An Updated Analysis of the ASPIRE Study
Nolan, B.
Young, G.
Mahlangu, J. N.
Liesner, R.
Pasi, K. J.
Yuan, H.
Winding, B.
Ramirez-Santiago, A.
Dumont, J.
Lethagen, S.
Glazebrook, D. V.
HAEMOPHILIA, 2017, 23 : 42 - 43
[4] Long-term efficacy of recombinant factor VIII Fc fusion protein (rFVIIIFc) in adults/adolescents with severe hemophilia A: United States subgroup analysis of A-LONG and ASPIRE
Quon, Doris V.
Young, Guy
Ragni, Margaret V.
Konkle, Barbara A.
Kulkarni, Roshni
Shapiro, Amy D.
Feng, Jingyuan
Cristiano, Lynda M.
Allen, Geoffrey
HAEMOPHILIA, 2016, 22 : 50 - 50
[5] Long-term Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) Prophylaxis in Adults, Adolescents, and Children with Severe Hemophilia A: Longitudinal Analysis of A-LONG and ASPIRE Studies
Konkle, B.
Pasi, K.
Young, G.
Recht, M.
Quon, D.
Tsao, E.
Winding, B.
Lethagen, S.
Glazebrook, D.
HAEMOPHILIA, 2017, 23 : 21 - 22
[6] Longitudinal Analysis of Long-Term Safety and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIFc) in Adults/Adolescents with Severe Hemophilia a
Konkle, Barbara
Pasi, K. John
Perry, David J.
Mahlangu, Johnny
Rangarajan, Savita
Brown, Simon A.
Hanabusa, Hideji
Pabinger, Ingrid
Cristiano, Lynda M.
Tsao, Elisa
Winding, Bent
Glazebrook, Desilu
Lethagen, Stefan
Jackson, Shannon
BLOOD, 2016, 128 (22)
[7] Longitudinal Analysis of Long-Term Safety and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Children with Severe Hemophilia a
Young, Guy
Liesner, Raina
Pasi, K. John
Nolan, Beatrice
Lethagen, Stefan
Cristiano, Lynda M.
Tsao, Elisa
Winding, Bent
Mahlangu, Johnny
BLOOD, 2016, 128 (22)
[8] Long-Term Safety and Efficacy of Recombinant Factor VIII FC Fusion Protein (rFVIIIFc) in Adults and Adolescents with Severe Haemophilia A: An Updated Interim Analysis of the Aspire Study
Pasi, K. J.
Perry, D. J.
Mahlangu, J.
Konkle, B. A.
Rangarajan, S.
Brown, S. A.
Hanabusa, H.
Jackson, S.
Pabinger, I.
Cristiano, L. M.
Lethagen, S.
Li, X.
Pierce, G. F.
Allen, G.
HAEMOPHILIA, 2016, 22 : 64 - 65
[9] Long-term safety and efficacy of recombinant factor VIII Fc fusion protein (rFVIIIFc) in subjects with haemophilia A
Nolan, B.
Mahlangu, J.
Perry, D.
Young, G.
Liesner, R.
Konkle, B.
Rangarajan, S.
Brown, S.
Hanabusa, H.
Pasi, K. J.
Pabinger, I.
Jackson, S.
Cristiano, L. M.
Li, X.
Pierce, G. F.
Allen, G.
HAEMOPHILIA, 2016, 22 (01) : 72 - 80
[10] THE CLINICAL AND ECONOMIC IMPACT OF RECOMBINANT FACTOR VIII FC FUSION PROTEIN (RFVIIIFC) ON LONG-TERM JOINT HEALTH IN PEOPLE WITH HEMOPHILIA A (PWHA)
Batt, K.
Cockerham, A.
Sacks, N.
Jin, H.
Nguyen, A. T. H.
HAEMOPHILIA, 2022, 28 : 93 - 94

← 1 2 3 4 5 →